Elsevier’s ClinicalPath is now a Recognized Quality Solution for the ASCO Certified Program

Elsevier today announced that ClinicalPath, its oncology decision support solution, has been designated a Recognized Quality Solution (RQS) by the Association for Clinical Oncology for the ASCO Certified program, reinforcing its role in advancing high-quality, patient-centered cancer care.

Omry Bigger, President, Clinical Solutions, Elsevier said “Cancer practices want to deliver the best care possible, and this recognition means they can be even more confident in the value ClinicalPath provides. Being able to support cancer practices with their reporting requirements is a crucial element of the RQS designation, and we look forward to taking this step forward with our customers.”

Clifford A. Hudis, MD, FACP, FASCO, CEO of ASCO said, "We are pleased to designate Elsevier's ClinicalPath as a Recognized Quality Solution. ClinicalPath underwent a rigorous validation process that reviewed the necessary data elements for clinical quality measurement and pathway utilization. This recognition demonstrates Elsevier's commitment to assisting practices with meeting certification requirements."

With ClinicalPath, cancer centers can:

• Deliver consistent high-quality, patient-centered care aligned with ASCO Certified standards

• Leverage evidence-based pathways driven by the latest research, updated content, and integrated clinical trials

• Streamline quality reporting and compliance with automated capture of pathway utilization and on/off pathway data

• Enhance credibility and align with payers through support for value-based care models

You can find out more about ClinicalPath here.

About ASCO Certified

ASCO Certified is a practice certification demonstrating oncology patient-centered care based on the Oncology Medical Home (OMH) Standards from the American Society of Clinical Oncology and the Community Oncology Alliance (COA). These standards aim to establish core elements needed to deliver high-quality cancer care and achieve broad consensus among all stakeholders on what patients with cancer should expect and receive from their cancer care teams.

Acerca de Elsevier

Elsevier es líder global en información avanzada y soporte para la toma de decisiones. Durante más de un siglo, ha ayudado a avanzar la ciencia y la salud para promover el progreso humano. Apoya a comunidades de investigación académicas y corporativas, médicos, enfermeras, futuros profesionales de la salud y educadores en 170 países, proporcionándoles conocimientos críticos y soluciones innovadoras que combinan contenido científico y médico confiable con tecnologías de IA de vanguardia. Elsevier promueve la inclusión y la sostenibilidad incorporando estos valores en sus productos y cultura. La Elsevier Foundation respalda investigaciones y asociaciones de salud alrededor del mundo.

Elsevier forma parte de RELX, proveedor global de herramientas de análisis y decisión basadas en información para clientes profesionales y de negocios. Para más información, visite www.elsevier.com y síganos en redes sociales: @ElsevierConnect.